24356 Investors following Sun Pharma. Share this News with them.
0
Like this story, share it with millions of investors on M3
Sun Pharma get tentative USFDA nod for drug
Sun Pharmaceuticals Ltd said on Thursday it has received tentative United States Food and Drug Administration's approval for its generic Strattera capsules.
Sun Pharmaceuticals Ltd said on Thursday it has received tentative United States Food and Drug Administration's approval for its generic Strattera capsules.
The company has received Abbreviated New Drug Application for the drug, which is used for treatment of attention deficit hyperactivity disorder, it said in a statement to the exchange.
The drug is a therapeutic equivalent of Strattera capsules from Eli Lily.